TrialArthritis & rheumatology (Hoboken, N.J.)2021

Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.

David Roofeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.